The current price of NUVL is $123.96 — it has remained unchanged since the previous close. Data as of Jul 15, 2026.
NUVL is flat over the past week, flat over the past month and up 61.41% over the past year. The price is above its 200-day moving average of $103.43.
Analysts' average 12-month price target for NUVL is $127.32, which implies 2.71% upside from the current price. Individual estimates range from $122.85 to $165.00.
Of the 17 analysts covering Nuvalent, Inc., 17 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Nuvalent, Inc. has a market capitalization of $9.13B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Nuvalent, Inc. has not paid any dividends over the past year.
In the latest trading session NUVL moved between $123.96 and $123.96, a range of 0.00% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Nuvalent, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Nuvalent, Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks NUVL has traded between $87.30 and $123.99. The current price is at its 52-week high.
Figures as of Jul 15, 2026. This information is provided for general purposes only and is not investment advice.